MENU
RGNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
REGENXBIO (RGNX) Ownership - Who owns REGENXBIO?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
344
Web
https://www.regenxbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
366.63M
P/E Ratio
N/A
Total Cash
255.46M
Projected Growth
N/A
Total Debt
84.06M
Revenue
84.33M
Risk (Beta)
1.67
Dividend Yield
N/A
Total Cash/Share
5.16
Total Debt/Equity
N/A
Revenue/Share
1.76 USD as % of share price
Fundamentals
RGNX
Capitalization
367M
P/E Ratio
N/A
Risk (Beta)
1.67
Dividend Yield
N/A
Total Cash
255M
Total Cash/Share
5.16
Total Debt
84.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.76%
Revenue
84.3M
ROE
N/A
Book Value
301M
P/B Ratio
1.22
Cash Flow
N/A
Earnings
-5.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
3.05
Current Revenue Per Employee
70340.12
Dividends Per Share - Security
N/A
EBITDA
-217.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
48.81
Revenue To Assets
-41.43
Shares Held By Institutions
698M
Shares Outstanding - Current
49.5M
Total Liabilities
218M
Total Volume MTD
N/A
Value
-1
Gain YTD
-58.774
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of gene therapy treatments
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
344
Web
https://www.regenxbio.com